IBACR
IB Acquisition Corp.
Key Financials
Net Income
$3.4M
↑ 82.9%
Operating Income
$-748908
↓ 42.9%
Shareholders' Equity
$-681323.00
↓ 161.3%
Total Assets
$17.1M
↓ 85.7%
Total Liabilities
$1.8M
↑ 153.7%
Cash & Equivalents
$428700.00
↓ 47.9%
Operating Cash Flow
$-1318100.00
↓ 60.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/30/2026 | View on SEC |
| 8-K/A | 9/23/2026 | View on SEC |
| 425 | 9/23/2026 | View on SEC |
| 425 | 9/23/2026 | View on SEC |
| 425 | 9/21/2026 | View on SEC |
| 8-K | 9/21/2026 | View on SEC |
| DEF 14A | 9/4/2026 | View on SEC |
| PRE 14A | 8/25/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| S-4 | 7/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IBACR |
| Company Name | IB Acquisition Corp. |
| CIK | 1998781 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | NV |
| Phone | 214-687-0020 |